Report Overview: The Global Hydroxychloroquine Market achieved a valuation of $949.65 Million in 2022 and is anticipated to exceed $1446.43 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 5.4% during the forecast period from 2024 to 2032. Key Market Players: Sanofi, Amneal Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis AG,...